Palvella Therapeutics Inc...

NASDAQ: PVLA · Real-Time Price · USD
47.12
1.02 (2.21%)
At close: Aug 15, 2025, 3:59 PM
48.00
1.88%
After-hours: Aug 15, 2025, 05:20 PM EDT

Palvella Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-17.43M 18.69M -27.55M -45.74M
Depreciation & Amortization
n/a n/a n/a 2.37M
Stock-Based Compensation
830K 603K 427K n/a
Other Working Capital
-453K -904K -359K 25.29M
Other Non-Cash Items
5.96M -29.85M 10.66M 5.18M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-193K -3.15M 1.62M 30.52M
Operating Cash Flow
-10.84M -13.7M -14.84M -7.66M
Capital Expenditures
n/a n/a -1.04M -949K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a -48.4M n/a
Sales Maturities Of Investments
n/a n/a 28.2M n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a -21.24M -949K
Debt Repayment
78.43M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
8.65M 5M 34K n/a
Financial Cash Flow
87.09M 5M 9.57M 59.13M
Net Cash Flow
76.25M -8.7M -5.27M 47.33M
Free Cash Flow
-10.84M -13.7M -14.84M -8.61M